Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation
A D Pinna, S Iwatsuki, R G Lee, S Todo, J R Madariaga, J W Marsh, A Casavilla, I Dvorchik, J J Fung, T E Starzl – 30 December 2003 – Fibrolamellar hepatoma (FL‐HCC) is an uncommon variant of hepatocellular carcinoma (HCC), distinguished by histopathological features suggesting greater differentiation than conventional HCC. However, the optimal treatment and the prognosis of FL‐HCC have been controversial. Follow‐up studies are available from 1 year to 27 years, after 41 patients with FL‐HCC were treated with partial hepatectomy (PHx) (28 patients) or liver transplantation (13 patients).